Detailed information for compound 2074298

Basic information

Technical information
  • TDR Targets ID: 2074298
  • Name: [(2R)-1-[(2S)-2-amino-3-methylbutanoyl]pyrrol idin-2-yl]boronic acid; methanesulfonic acid
  • MW: 310.175 | Formula: C10H23BN2O6S
  • H donors: 4 H acceptors: 6 LogP: -3.5 Rotable bonds: 4
    Rule of 5 violations (Lipinski): 1
  • SMILES: CS(=O)(=O)O.CC([C@@H](C(=O)N1CCC[C@H]1B(O)O)N)C
  • InChi: 1S/C9H19BN2O3.CH4O3S/c1-6(2)8(11)9(13)12-5-3-4-7(12)10(14)15;1-5(2,3)4/h6-8,14-15H,3-5,11H2,1-2H3;1H3,(H,2,3,4)/t7-,8-;/m0./s1
  • InChiKey: OXYYOEIGQRXGPI-WSZWBAFRSA-N  

Network

Hover on a compound node to display the structore

Synonyms

  • [(2R)-1-[(2S)-2-amino-3-methyl-butanoyl]pyrrolidin-2-yl]boronic acid; methanesulfonic acid
  • [(2R)-1-[(2S)-2-amino-3-methyl-1-oxobutyl]-2-pyrrolidinyl]boronic acid; methanesulfonic acid
  • 150080-09-4
  • D05990
  • Talabostat mesylate
  • Talabostat mesylate (USAN)

Targets

Known targets for this compound

No curated genes were found associated with this compound

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Brugia malayi Choline/Carnitine o-acyltransferase family protein 0.0147 0.1448 0.4017
Echinococcus granulosus CREB binding protein 0.0182 0.1883 0.5493
Loa Loa (eye worm) hypothetical protein 0.0147 0.1448 0.6151
Echinococcus granulosus carnitine O palmitoyltransferase 2 0.005 0.0225 0.01
Echinococcus granulosus glycylpeptide N tetradecanoyltransferase 0.0167 0.1693 0.4876
Schistosoma mansoni choline o-acyltransferase 0.0209 0.2212 0.653
Echinococcus multilocularis carnitine O palmitoyltransferase 1, liver 0.0147 0.1448 0.6209
Trichomonas vaginalis bromodomain-containing protein, putative 0.0077 0.056 0.3307
Trichomonas vaginalis N-myristoyl transferase, putative 0.011 0.0976 0.5764
Trypanosoma cruzi N-myristoyl transferase, putative 0.0167 0.1693 1
Brugia malayi TAZ zinc finger family protein 0.0293 0.3268 1
Schistosoma mansoni gcn5proteinral control of amino-acid synthesis 5-like 2 gcnl2 0.0195 0.2046 0.5983
Echinococcus multilocularis gcn5proteinral control of amino acid synthesis 0.0195 0.2046 0.9175
Echinococcus multilocularis choline O acetyltransferase 0.0209 0.2212 1
Loa Loa (eye worm) hypothetical protein 0.0209 0.2212 1
Toxoplasma gondii histone lysine acetyltransferase GCN5-B 0.0077 0.056 0.5
Echinococcus granulosus CREB binding protein 0.0293 0.3268 1
Brugia malayi N-myristoyltransferase 2 0.0167 0.1693 0.4824
Echinococcus multilocularis CREB binding protein 0.0202 0.2133 0.9604
Loa Loa (eye worm) acetyltransferase 0.0195 0.2046 0.9162
Loa Loa (eye worm) choline O-acetyltransferase 0.0209 0.2212 1
Brugia malayi Choline O-acetyltransferase 0.0209 0.2212 0.653
Trypanosoma cruzi N-myristoyl transferase, putative 0.0167 0.1693 1
Trypanosoma cruzi choline/carnitine O-acyltransferase, putative 0.0147 0.1448 0.8326
Onchocerca volvulus 0.005 0.0225 0.5
Trichomonas vaginalis cat eye syndrome critical region protein 2, cscr2, putative 0.0077 0.056 0.3307
Echinococcus multilocularis glycylpeptide N tetradecanoyltransferase 0.0167 0.1693 0.7427
Plasmodium falciparum glycylpeptide N-tetradecanoyltransferase 0.0167 0.1693 1
Echinococcus multilocularis carnitine O palmitoyltransferase 2 0.005 0.0225 0.0152
Brugia malayi acetyltransferase, GNAT family protein 0.0195 0.2046 0.5983
Schistosoma mansoni CREB-binding protein 2 0.0293 0.3268 1
Brugia malayi Choline O-acetyltransferase 0.0209 0.2212 0.653
Trypanosoma cruzi choline/carnitine O-acyltransferase, putative 0.0147 0.1448 0.8326
Onchocerca volvulus 0.005 0.0225 0.5
Leishmania major choline/Carnitine o-acyltransferase-like protein 0.0147 0.1448 0.8326
Trypanosoma brucei N-myristoyltransferase 0.0167 0.1693 1
Echinococcus granulosus choline O acetyltransferase 0.0209 0.2212 0.6565
Echinococcus granulosus histone acetyltransferase KAT2B 0.0163 0.1648 0.4727
Entamoeba histolytica glycylpeptide N-tetradecanoyltransferase, putative 0.0167 0.1693 1
Trypanosoma brucei N-myristoyl transferase, putative 0.0167 0.1693 1
Giardia lamblia CDC72 0.0167 0.1693 1
Echinococcus granulosus carnitine O palmitoyltransferase 1 liver 0.0147 0.1448 0.4076
Onchocerca volvulus 0.005 0.0225 0.5
Toxoplasma gondii histone lysine acetyltransferase GCN5-A 0.0077 0.056 0.5
Mycobacterium tuberculosis Naphthoate synthase MenB (dihydroxynaphthoic acid synthetase) (DHNA synthetase) 0.0831 1 0.5
Loa Loa (eye worm) N-myristoyltransferase 2 0.0167 0.1693 0.7387
Loa Loa (eye worm) CBP-B 0.0205 0.2164 0.9756
Leishmania major N-myristoyl transferase, putative 0.0167 0.1693 1
Schistosoma mansoni CREB-binding protein 1 (SmCBP1) 0.0293 0.3268 1
Trichomonas vaginalis N-myristoyl transferase, putative 0.0167 0.1693 1
Mycobacterium ulcerans naphthoate synthase 0.0831 1 0.5
Schistosoma mansoni N-myristoyltransferase 0.0167 0.1693 0.4824
Echinococcus granulosus histone acetyltransferase KAT2B 0.0077 0.056 0.1189
Loa Loa (eye worm) hypothetical protein 0.0136 0.1299 0.5403
Plasmodium vivax glycylpeptide N-tetradecanoyltransferase, putative 0.0167 0.1693 1
Onchocerca volvulus 0.005 0.0225 0.5

Activities

No activities found for this compound.

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

No literature references available for this target.

If you have references for this compound, please enter them in a user comment (below) or Contact us.